Gaush Meditech Ltd (FRA:F7Y)

Gaush Meditech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	421.44	618.7	721.52	609	307.49
Short-Term Investments	-	38.74	90.54	-	-
Trading Asset Securities	97.55	175.53	2.1	-	0.01
Cash & Short-Term Investments	518.99	832.97	814.16	609	307.5
Cash Growth	-37.69%	2.31%	33.69%	98.05%	-42.30%
Receivables	167.7	149.09	168.64	171.99	172.99
Inventory	334.42	328.53	281.12	240.11	239.57
Other Current Assets	129.66	80.25	62.41	68.69	28.98
Total Current Assets	1,151	1,391	1,326	1,090	749.04
Property, Plant & Equipment	124.01	126.08	126.75	85.53	31.87
Goodwill	910.51	961.39	906.87	882.7	31.23
Other Intangible Assets	294.42	269.83	278.88	303.89	21.75
Long-Term Accounts Receivable	-	-	-	0.08	0.65
Long-Term Deferred Tax Assets	47.77	57.01	56.27	40.85	13.8
Other Long-Term Assets	38.83	38.58	22.98	23.84	1,387
Total Assets	2,566	2,844	2,718	2,427	2,236
Accounts Payable	70.34	90.56	68.7	68.02	104.42
Accrued Expenses	-	-	-	-	95.15
Short-Term Debt	-	-	-	84.22	803.14
Current Portion of Long-Term Debt	170.63	523.27	131.88	38.54	63.05
Current Portion of Leases	20.16	14.32	19.24	12.6	6.23
Current Income Taxes Payable	17.66	5.2	13.58	19.79	28.83
Current Unearned Revenue	103.86	125.46	136.05	93.88	121.58
Other Current Liabilities	129.16	132.86	123.18	124.18	58.11
Total Current Liabilities	511.81	891.67	492.62	441.24	1,281
Long-Term Debt	337.1	95.29	569.71	2,455	858.55
Long-Term Leases	24.35	31.48	35.18	31.78	13.89
Long-Term Unearned Revenue	31.66	29.97	26.89	29.26	29.26
Long-Term Deferred Tax Liabilities	57.15	66.55	71.95	66.37	5.76
Other Long-Term Liabilities	16.06	31.76	35.05	36.54	-
Total Liabilities	978.12	1,147	1,231	3,060	2,188
Common Stock	0.1	0.1	0.1	0.07	0.07
Retained Earnings	-	1,672	1,497	-236.83	-46.38
Treasury Stock	-11.69	-	-	-	-
Comprehensive Income & Other	1,587	8.77	-27.07	-419.67	71.94
Total Common Equity	1,575	1,680	1,470	-656.43	25.63
Minority Interest	13.05	16.52	17.13	23.06	22.19
Shareholders' Equity	1,588	1,697	1,487	-633.37	47.81
Total Liabilities & Equity	2,566	2,844	2,718	2,427	2,236
Total Debt	552.24	664.36	756	2,622	1,745
Net Cash (Debt)	-33.24	168.61	58.16	-2,013	-1,437
Net Cash Growth	-	189.92%	-	-	-
Net Cash Per Share	-0.22	1.14	0.60	-21.00	-13.64
Filing Date Shares Outstanding	147.89	147.97	147.93	107.22	105.35
Total Common Shares Outstanding	147.89	147.97	147.93	94.15	105.35
Working Capital	638.96	499.17	833.71	648.55	-531.46
Book Value Per Share	10.65	11.36	9.93	-6.97	0.24
Tangible Book Value	370.21	449.25	283.8	-1,843	-27.35
Tangible Book Value Per Share	2.50	3.04	1.92	-19.58	-0.26
Machinery	-	92.29	68.13	44.44	19.08
Construction In Progress	-	-	4.06	-	-
Leasehold Improvements	-	31.67	26.13	14.55	6.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.